In November 2014 Actavis, plc announced its intention to acquire Allergan, Inc., the manufacturer of Botox[REF] Completion of the deal would increase its market capitalization to $147 billion [REF].
In June Allergan, Inc. announced it would acquire Kythera Biopharmaceuticals for around $2.1 billion [REF].